Cocrystal Pharma, Inc. (COCP) stock
COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.98−0.01 (-1.00%)
Close on Nov 13, 2026Market cap $18.88MP/E –Yield –
Cocrystal Pharma operating margin
Operating margin is operating income as a percentage of revenue.
Cocrystal Pharma's operating margin for the twelve months ending Dec 31, 2020 was -476.0%. For fiscal 2020 it was -476.0%, against -737.4% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -476.0% | +261.5 |
| FY2019 | Dec 31, 2019 | -737.4% | −706.9 |
| FY2011 | Dec 31, 2011 | -30.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -3032.4% | −2409.6 |
| Q1 FY2026 | Mar 31, 2026 | -1047.1% | −621.7 |
| Q4 FY2020 | Dec 31, 2020 | -287.5% | +11634.2 |
| Q3 FY2020 | Sep 30, 2020 | -554.0% | −186.5 |
| Q2 FY2020 | Jun 30, 2020 | -622.7% | −360.9 |
| Q1 FY2020 | Mar 31, 2020 | -425.4% | −482.0 |
| Q4 FY2019 | Dec 31, 2019 | -11921.6% | – |
| Q3 FY2019 | Sep 30, 2019 | -367.5% | – |
| Q2 FY2019 | Jun 30, 2019 | -261.8% | – |
| Q1 FY2019 | Mar 31, 2019 | 56.7% | – |
See a number that looks wrong?